For men wanting to prevent the development of prostate cancer, the following seven foods are worth keeping on the shopping list. Read the article here.
Men: Prostate Cancer Is On The Rise. Here Are 7 Foods To Stop It Read More »
Magnetic resonance imaging before biopsy for prostate-cancer detection is superior to standard transrectal ultrasonography-guided biopsy among men at risk for prostate cancer, according to a study published in the New England Journal of Medicine. Read the article here.
Prostate MRI Detects More Cancers Than Standard US-Guided Biopsy Read More »
March 2018 Awareness Night How clinical trials have changed prostate cancer care Dr. Andrew Loblaw BSc MD MSc FRCPC CIP Clinician Scientist , Ontario Association of Radiation OncologyStaff Radiation Oncologist & Clinician Scientist, Sunnybrook Health Sciences Centre Scientist, Sunnybrook Research Institute Fellow, American Society of Clinical Oncology (ASCO) Co-Chair, GU group for Cancer Care Ontario’s Program in Evidence-Based Care Previous Co-Chair, ASCO’s Genitourinary Advisory Group Professor, Department of Radiation Oncology at University of Toronto Professor,The Institute of Health Policy, Management and Evaluation (IHPME) CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 66:27 minutes
Video: “How clinical trials have changed prostate cancer care” Read More »
Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter. In this Issue: April Fools page Giampaolo (Paul) Fiaschi – 1933-2018 Ask the Health Care Team (was Ask the Doctor) – Prostate Cancer and Exercise Coming Awareness Night – Carrie Poteck (M.Ed.) – An evening on exercise, diet and well being! June 17th, 2018 is our Father`s Day “Do It For Dads” walk/run at Ashbridges Bay January Janssen Awareness Night: Dr. Stanley Flax & Dr. Adam Tunis – Perineal biopsies and the role of imaging March Awareness Night: Dr. Andrew Loblaw – How clincal trials have changed prostate
Newsletter April 2018 Read More »
A substantial proportion of men with low-risk prostate cancer can safely be followed with a de-intensified active surveillance protocol. Read the article here.
When can active surveillance be less active? Read More »
For men with metastatic prostate cancer there is no survival advantage for aggressive therapy over conservative androgen deprivation therapy only, according to a study. Read the article here.
No Benefit for Aggressive Therapy in Metastatic Prostate Cancer Read More »
A greater than 90-day delay from prostate biopsy to radical prostatectomy for localized prostate cancer may increase the risk of biochemical recurrence of disease, according to study findings. Read the article here.
Biopsy-to-RP Delay May Up Prostate Cancer Recurrence Risk Read More »
Gay men with prostate cancer have unmet information and supportive care needs throughout their prostate cancer journey. Read the article here.
Exploring the lived experience of gay men with prostate cancer Read More »
A new study shows that a mix of different treatments, or a “multimodal” approach to prostate cancer therapy, lengthens survival in men who have this diagnosis. Read the article here.
A mix of treatments may extend life for men with aggressive prostate cancer Read More »
A drug used to treat enlarged prostate or hair loss in men has been shown to have a long-term protective effect against prostate cancer. Read the article here.
Finasteride can reduce prostate cancer risk long term Read More »